RxDoctor Payments DataLook up a doctor →

Edgardo Santos, MD

Hematology & Oncology · Fort Lauderdale, FLNPI 1639260771

Payments from drug & device makers

$2,339,352in general payments, 2019–2025

Across 2,521 payments — averaging $927.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$253K
  • Jazz Pharmaceuticals Inc.$221K
  • Regeneron Healthcare Solutions, Inc.$210K
  • Merck$160K
  • Lilly USA, LLC$148K
  • Takeda Pharmaceuticals U.S.A., Inc.$128K
  • plus $1.2M from 54 others
$14,111in research payments, 2019–2025

Across 11 payments — averaging $1282.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$11K
  • Eli Lilly$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)289$253,471
Jazz Pharmaceuticals Inc.140$220,642
Regeneron Healthcare Solutions, Inc.147$209,687
Merck173$160,495
Lilly USA, LLC171$148,011
Takeda Pharmaceuticals U.S.A., Inc.80$127,682
Johnson & Johnson(2 entities)153$122,029
E.r. Squibb & Sons, L.L.C.104$104,481
EMD Serono, Inc.83$91,582
Pfizer132$89,805
Sanofi64$79,854
Janssen Research & Development, LLC11$78,496
Amgen143$75,823
Boehringer Ingelheim48$72,332
Genentech USA, Inc.82$55,100
Genentech, Inc.7$52,130
G1 Therapeutics, Inc.42$49,254
Mirati Therapeutics, Inc.30$44,499
Tesaro, Inc.3$41,612
Bristol Myers Squibb45$38,709
Dova Pharmaceuticals17$28,996
Novartis63$23,589
Janssen Scientific Affairs, LLC22$21,862
Puma Biotechnology, Inc.5$16,880
Eli Lilly11$16,607
AbbVie22$15,945
Novocure Inc.22$12,471
Eli Lilly Export S.A. Puerto Rico Branch4$9,450
Bayer18$8,866
Coherus Oncology, Inc.21$8,305
Incyte Corporation11$8,179
Catalyst Pharmaceuticals, Inc.1$5,500
Immunitybio, Inc.2$5,000
Sobi, Inc8$4,985
Sanofi-aventis U.S. LLC3$4,936
Astellas Pharma US Inc30$4,714
Daiichi Sankyo Inc.35$4,389
Partner Therapeutics, Inc.10$4,237
Taiho Oncology, Inc.9$4,047
Fujirebio Diagnostics, Incorporated1$2,258
Astrazeneca UK Limited2$2,145
Sirtex Medical Inc14$1,309
Pharmacosmos Therapeutics Inc.9$1,076
Array Biopharma Inc21$1,070
Gilead(2 entities)9$626
ADC Therapeutics America, Inc.6$591
Pfizer ZONA Franca, S.A.1$535
Seagen Inc.20$533
GSK25$505
Tempus AI, Inc12$353
Eisai Inc.9$324
Pharmacyclics LLC, An Abbvie Company13$308
Rigel Pharmaceuticals, Inc.7$274
Exelixis Inc.13$272
Adaptive Biotechnologies Corporation3$203
Karyopharm Therapeutics Inc.7$171
Deciphera Pharmaceuticals Inc.7$169
AVEO Pharmaceuticals, Inc.4$167
Regeneron2$139
Foundation Medicine, Inc.5$125

How this compares

$2,339,352 in reported general payments places this provider in the 90th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Medicare billing

Part B allowed, 2024
$128,693
Medicare patients
12
Services billed
5,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Fort Lauderdale

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →